Spark Investment Management’s EPIRUS BIOPHARMACEUTICALS INC COM EPRS Stock Holding History

Spark Investment Management’s Portfolio EPRS Stock Details EPRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-93,900	Closed	-$290K	–	940
2015 Q4	$290K	Buy	+93,900	New	+$423K	0.04%	489
2015 Q3	–	Sell	-17,900	Closed	-$102K	–	866
2015 Q2	$102K	Sell	17,900 -40,800	-70%	-$278K	0.01%	595
2015 Q1	$524K	Buy	58,700 +41,100	+234%	+$330K	0.07%	361
2014 Q4	$98K	Buy	+17,600	New	+$92K	0.02%	583

Other funds holding EPRS

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Bailard Foster City, California $4.35B AUM 23.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Spark Investment Management's EPRS Position: Q1 2016 in Review

Spark Investment Management sold out of EPIRUS BIOPHARMACEUTICALS INC COM (EPRS) in Q1 2016, closing a stake of 93,900 shares — an estimated $290K sold.

Spark Investment Management first reported a position in EPRS in Q4 2014 and held it in 4 quarters. The position peaked at $524K in Q1 2015. 37 funds tracked by Wall St. Rank hold EPRS as of Q1 2016.

Spark Investment Management reported no remaining EPIRUS BIOPHARMACEUTICALS INC COM position as of Q1 2016 after selling out during the quarter.
Spark Investment Management sold 93,900 EPIRUS BIOPHARMACEUTICALS INC COM shares in Q1 2016, an estimated $290K.
Spark Investment Management first reported a position in EPIRUS BIOPHARMACEUTICALS INC COM in Q4 2014 and held it in 4 quarters.
Spark Investment Management's EPIRUS BIOPHARMACEUTICALS INC COM position peaked at $524K in Q1 2015.
37 funds tracked by Wall St. Rank held EPIRUS BIOPHARMACEUTICALS INC COM as of Q1 2016.

Based on Spark Investment Management's 13F filing for Q1 2016, filed 12 May 2016.